These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6354151)

  • 1. Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.
    Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Weiner HL
    Arch Neurol; 1983 Oct; 40(11):687-90. PubMed ID: 6354151
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis in multiple sclerosis: prospective trial of pheresis and immunosuppression versus immunosuppression alone.
    Tindall RS; Walker JE; Ehle AL; Near L; Rollins J; Becker D
    Neurology; 1982 Jul; 32(7):739-43. PubMed ID: 7201110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
    Weiner HL; Dau PC; Khatri BO; Petajan J; Birnbaum G; McQuillen MP; Fosburg MT; Feldstein M; Orav J
    Prog Clin Biol Res; 1990; 337():283. PubMed ID: 2162062
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasmapheresis with immunosuppressive drug therapy in progressive multiple sclerosis. A pilot study.
    Khatri BO; Koethe SM; McQuillen MP
    Arch Neurol; 1984 Jul; 41(7):734-8. PubMed ID: 6234867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scoring techniques and problems in the evaluation of change in patients.
    Slater RJ
    Arch Neurol; 1983 Oct; 40(11):675-7. PubMed ID: 6625974
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intensive immunosuppression in progressive multiple sclerosis. An open study comparing 3 groups: cyclophosphamide, cyclophosphamide-plasmapheresis and control subjects. Results after 3 years].
    Trouillas P; Neuschwander P; Nighoghossian N; Adeleine P; Tremisi P
    Rev Neurol (Paris); 1989; 145(5):369-77. PubMed ID: 2662340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmapheresis in chronic progressive multiple sclerosis: pro.
    McQuillen MP
    J Clin Apher; 1991; 6(4):207-10. PubMed ID: 1816242
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental therapies for multiple sclerosis: current status.
    Goodkin DE; Ransohoff RM; Rudick RA
    Cleve Clin J Med; 1992; 59(1):63-74. PubMed ID: 1372538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic trials in multiple sclerosis.
    Noseworthy JH; Seland TP; Ebers GC
    Can J Neurol Sci; 1984 Aug; 11(3):355-62. PubMed ID: 6205737
    [No Abstract]   [Full Text] [Related]  

  • 10. Experience with cyclophosphamide in multiple sclerosis: the cons.
    Likosky WH
    Neurology; 1988 Jul; 38(7 Suppl 2):14-8. PubMed ID: 3290708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of lymphocytapheresis plus cyclophosphamide on the course of a chronic progressive form of multiple sclerosis.
    Ferla S; Meneghetti G; Spartà S; Belloni M; Ongaro G
    Ital J Neurol Sci; 1985 Sep; 6(3):283-6. PubMed ID: 4066266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive drug therapy with plasmapheresis in chronic progressive multiple sclerosis: a controlled study.
    Khatri BO; Harrington GJ; Schmoll D; McQuillen MP
    J Clin Apher; 1984; 2(1):135-7. PubMed ID: 6536654
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic progressive multiple sclerosis: double-blind controlled study of plasmapheresis in patients taking immunosuppressive drugs.
    Khatri BO; McQuillen MP; Harrington GJ; Schmoll D; Hoffmann RG
    Neurology; 1985 Mar; 35(3):312-9. PubMed ID: 3974889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense immunosuppression in chronic progressive multiple sclerosis: the Kaiser study.
    Likosky WH; Fireman B; Elmore R; Eno G; Gale K; Goode GB; Ikeda K; Laster J; Mosher C; Rozance J
    J Neurol Neurosurg Psychiatry; 1991 Dec; 54(12):1055-60. PubMed ID: 1783915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL; Fosburg M; Kevy S; Weiner HL
    Prog Clin Biol Res; 1982; 106():239-54. PubMed ID: 6184727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A closer look at plasmapheresis in multiple sclerosis: the cons.
    Tindall R
    Neurology; 1988 Jul; 38(7 Suppl 2):53-6. PubMed ID: 3290716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
    Hommes OR
    Ned Tijdschr Geneeskd; 1978 Oct; 122(41):1545-51. PubMed ID: 358004
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma exchange in acute multiple sclerosis. Design of a cooperative study.
    Weiner HL; Dau P; Birnbaum G; Feldstein M; Khatri B; Petajan J; McQuillen MP
    Arch Neurol; 1983 Oct; 40(11):691-2. PubMed ID: 6354152
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of cyclophosphamide in the treatment of multiple sclerosis.
    Weiner HL; Hauser SL; Hafler DA; Fallis RJ; Lehrich JR; Dawson DM
    Ann N Y Acad Sci; 1984; 436():373-81. PubMed ID: 6099707
    [No Abstract]   [Full Text] [Related]  

  • 20. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
    Hauser SL; Dawson DM; Lehrich JR; Beal MF; Kevy SV; Propper RD; Mills JA; Weiner HL
    N Engl J Med; 1983 Jan; 308(4):173-80. PubMed ID: 6294517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.